Royalty Pharma PLC 13F institutional holdings
Quarterly disclosures of US equity positions held by institutional managers with over $100 million under management.
NASDAQ
Royalty Pharma plc reported 0 holdings worth $0 for the period ended June 30, 2026.
NASDAQ
Royalty Pharma plc has filed a Form 13F-NT with the SEC for the quarter ended March 31, 2026, indicating no new holdings are reported in this filing.
NASDAQ
Royalty Pharma plc filed a 13F-NT notice for the quarter ended December 31, 2025, indicating its holdings are reported by a sub-manager.